Related by context. All words. (Click for frequent words.) 67 invasive lobular 66 atypical hyperplasia 65 ovarian endometrial 65 unexplained vaginal bleeding 64 ductal breast cancer 64 lobular cancer 64 malignant polyps 64 dysplastic lesions caused 64 Hormone pills 64 endometrial cancers 63 precursor lesions 63 endometrial hyperplasia 63 advanced adenomas 62 gynecologic malignancy 62 HER2 amplified 62 tanned indoors 62 irregular menstrual cycles 62 uterus womb 62 Colon polyps 62 nonmelanoma 62 hormone receptor negative 62 anal lesions 62 breast uterine 61 nonmelanoma skin cancers 61 castration resistant hormone refractory 61 faulty BRCA genes 61 precancerous tumors 61 lobular breast cancer 61 Uterine cancer 61 atypical ductal hyperplasia 61 colorectal neoplasms 60 perimenopausal women 60 progesterone receptor negative 60 endometrial carcinoma 60 detecting precancerous 60 subclinical hyperthyroidism 60 adenomatous polyps 60 Basal cell 60 irregular menstrual periods 60 polycystic ovary syndrome PCOS 60 testicular tumors 60 unneeded biopsies 60 underarm lymph nodes 60 precancerous cervical 60 Squamous cell 60 thyrotropin levels 60 Basal Cell 60 ductal carcinomas 60 melanoma lesions 60 detect precancerous lesions 60 fibroids endometriosis 60 basal cell nevus syndrome 60 hormonally sensitive 60 breast endometrial 60 invasive carcinoma 60 Hurthle cell 60 colon rectum breast 59 ovarian lung 59 contralateral breast 59 pituitary adenomas 59 bladder ovarian 59 pre eclamptic 59 overexpress HER2 59 ductal cancer 59 testicular germ cell 59 nonproliferative 59 atypical lobular hyperplasia 59 endometriosis ovarian cysts 59 osteosarcomas 59 colorectal polyp 59 HER2 positive breast 59 premalignant lesion 59 squamous cell cancers 59 abnormal pap smear 59 impair fertility 59 precancerous polyp 59 Her2 positive 59 fibrocystic disease 59 neurofibromas 59 undergone radical prostatectomy 59 bladder cancers 59 nodal metastasis 59 epithelial ovarian 59 Chlamydia infection 59 advanced adenoma 58 develop premenopausal breast 58 premalignant lesions 58 undergoing hysterectomy 58 chewed sugarless gum 58 benign polyps 58 Heavy menstrual bleeding 58 azoospermia 58 anthracycline taxane 58 HER2 positive tumors 58 ovarian cervical 58 Fibroid tumors 58 thyroid hormone levels 58 TNF blocker therapy 58 pre cancerous polyps 58 benign nodules 58 radiosensitive 58 pancreatic lung 58 prolonged QT interval 58 precancerous condition 58 intestinal polyps 58 anal cancers 58 vulvar cancers 58 mutated BRAF gene 58 androgen suppression therapy 58 sentinel nodes 58 cervical lesions 58 BRCA1 mutation carriers 58 curable cancers 58 situ LCIS 58 fibrocystic changes 58 cancerous lumps 58 basal cell cancers 58 gastric corpus 58 denser breasts 58 abnormal pap smears 58 Ovarian cysts 58 thromboembolisms 58 nonmelanoma skin cancer 58 Brain metastases 58 postoperative pathology 58 abnormal Pap test 58 abnormal mammograms 58 leiomyomas 58 PAP smears 58 prolonged immobilization 58 apocrine 58 SHBG levels 58 microcalcifications 57 Endometrial cancer 57 genital lesions 57 inherited mutations 57 benign noncancerous 57 Squamous cell carcinomas 57 advanced neoplasia 57 got Abbott MitraClip 57 BRCA deficient 57 ovarian breast 57 KRAS oncogene 57 dysplastic lesions 57 tumor histology 57 Menopausal hormone therapy 57 leukaemias 57 undergone hysterectomy 57 hamartomas 57 lymphomas leukemias 57 lobular carcinoma 57 Estrogen receptor positive 57 #.#ng/ml 57 unresectable tumors 57 Waxenberg herself 57 subclinical disease 57 cancerous nodules 57 endometrial breast 57 benign uterine 57 progestagen 57 abnormal mammogram 57 stent stenosis 57 bladder prostate 57 B7 H3 57 histologic subtype 57 molar pregnancy 57 squamous cell lung cancer 57 deCODE ProstateCancer TM 57 mammographically 57 Malignant tumors 57 malignant growths 57 noncancerous prostate 57 polycystic ovarian syndrome PCOS 57 aromatase inhibitor therapy 57 hormone refractory prostate 57 Soy isoflavones 57 RET PTC rearrangements 57 cancerdefine 57 pancreatic prostate 57 cervical precancers 57 K ras mutations 57 mastectomy chemotherapy 57 irregular menses 57 abnormal Pap smears 57 colorectal polyps 57 recurrent bladder 57 metastatic gastric 57 female hormones estrogen 57 pancreas esophagus 57 GBA mutations 56 neurologic complications 56 tibolone 56 thyroid carcinoma 56 pre cancerous growths 56 distal colon 56 pancreatic bladder 56 Testosterone gel 56 cisplatin resistant 56 chlamydial infection 56 undergoing radical prostatectomy 56 breast ovary 56 recurrent atrial fibrillation 56 ovarian uterine 56 hypermethylated 56 benign moles 56 hormones estrogen 56 naturally occurring estrogen 56 flutamide 56 malignant prostate 56 ano genital warts 56 invasive ductal 56 abnormal pap tests 56 uterine cervix 56 Dr Zorbas 56 Ovary removal 56 bladder tumors 56 anovulatory 56 mutated K ras 56 ovulatory cycles 56 distal colon cancer 56 clinically insignificant 56 basal cell skin 56 oral squamous cell 56 sex hormones estrogen 56 utero exposure 56 Carcinoid tumors 56 mutated BRCA1 56 cervix uteri 56 chorioamnionitis 56 HER2 expression 56 fatty breasts 56 clinically detectable 56 colon rectum 56 malignant ovarian 56 radioiodine therapy 56 amenorrhoea 56 intermittent exotropia 56 incidentalomas 56 LHRH receptor positive 56 p# mutation 56 breast cancer recurrences 56 uterine ovarian 56 abnormal growths 56 underwent coronary angiography 56 esthesioneuroblastoma rare form 56 menstrual abnormalities 56 thyroid nodules 56 androgen excess 56 colorectal adenoma 56 proximal colon 56 painless lump 56 pre cancerous lesion 56 BRCA2 mutations 56 Folate deficiency 56 recurrent ovarian 56 intravenous RSD# 56 anastrazole 56 vagina cervix 56 hamartoma 56 recurrent metastatic 56 bulge corresponds 56 colorectal bowel 56 gestational diabetes mellitus GDM 56 severe hepatic dysfunction 56 invasive carcinomas 56 renal cell carcinomas 56 nonhormonal 56 fewer uterine cancers 56 atypia 56 polyps growths 56 estrogen progestin therapy 56 prostate cancer metastases 56 causes genital warts 56 androgen ablation 56 poorer prognosis 56 woman ovulates 56 depot medroxyprogesterone acetate 56 lichen planus 56 shorter telomere length 55 prostate adenocarcinoma 55 colorectal neoplasia 55 noncancer 55 Papillary 55 hematopoietic cancers 55 asthma rhinitis 55 cervix vagina 55 invasive lobular carcinoma 55 undergo lumpectomy 55 lung esophageal 55 fibrocystic 55 penis scrotum 55 colorectal lung 55 deCODE BreastCancer 55 locoregional recurrence 55 colon rectal 55 conjugated equine estrogen 55 estrogen progestin combination 55 metastatic colorectal 55 prolonged QT intervals 55 undergo radical prostatectomy 55 hormone deprivation 55 axillary dissection 55 Squamous 55 transfusion syndrome 55 PSADT 55 hypokalemia hypomagnesemia 55 microbleeds 55 undergo prostate biopsy 55 brain lesions 55 hormone FSH 55 molecular abnormalities 55 cause mesothelioma asbestosis 55 HNSCC 55 aerodigestive tract 55 lymph node biopsies 55 tamoxifen Nolvadex ® 55 Genetic mutation 55 lumbar disk herniation 55 metastatic bladder 55 oral contraceptive pills 55 abdominal ultrasounds 55 Prostatitis 55 oncogenic HPV 55 prostate walnut 55 Henrik Leffers 55 mammographic density 55 esophagogastric junction 55 malignant neoplasm 55 lung cancer asbestosis 55 Genital warts 55 genitourinary tract 55 cervical intraepithelial neoplasia 55 benign lesions 55 prescribed statins 55 antiestrogen therapy 55 cardiotoxic 55 premature menopause 55 Urinary tract infections 55 underwent surgical resection 55 penile cancers 55 neoplasias 55 Homocysteine levels 55 genital abnormalities 55 intravenous bisphosphonates 55 abnormal uterine bleeding 55 tongue mouth pharynx 55 adenoma 55 adnexal mass 55 untreated celiac disease 55 gene BRCA2 55 cTnT 55 Pelvic Inflammatory Disease 55 Androgen deprivation therapy 55 gestational hypertension 55 lobular carcinomas 55 benign prostatic hypertrophy 55 glandular tissue 55 polyp recurrence 55 abnormal Pap smear 55 BRCA1 BRCA2 55 peritoneal cancer 55 benign breast 55 fetal malformations 55 Acute pancreatitis 55 oophorectomy 55 armpit lymph nodes 55 PLX STROKE targeting 55 pelvic lymph nodes 55 BRCA2 gene mutation 55 colonoscopy detects precancerous polyps 55 undescended testes 55 Radical prostatectomy 55 Genetic variants 55 Screening mammograms 55 MGUS 55 pulmonary dysfunction 55 Benign prostatic hyperplasia BPH 55 prostate ovarian 55 extracolonic findings 55 external genital lesions 55 gross hematuria 55 colorectum 55 BRCA1 mutations 55 CYT# potent vascular disrupting 55 childhood sunburns 55 GnRH agonists 55 fibroadenomas 55 adenomatous polyp 54 specific antigen PSA 54 parous women 54 receiving XGEVA 54 ovarian malignancy 54 catheter angiography 54 lung cancer NSCLC 54 chronic hepatitis cirrhosis 54 hormone androgen 54 Chlamydia trachomatis infection 54 slow metabolizers 54 PCNSL 54 prostate colon 54 rectal gonorrhea 54 umbilical hernias 54 salpingo oophorectomy 54 prostate abnormalities 54 pheochromocytomas 54 PBDE chemicals 54 GSTT1 54 pre malignant lesions 54 untreated metastatic melanoma 54 pelvic prolapse 54 HGPIN 54 lung pancreatic 54 cervical vaginal 54 biliary tract 54 underwent radical prostatectomy 54 orchitis 54 testicular dysgenesis syndrome 54 testicular cancers 54 precancerous prostate 54 artery calcification 54 prostates removed 54 induce ovulation 54 elevated CRP 54 Bone density 54 sarcosine 54 Chronic pancreatitis 54 pCR 54 delaying childbirth 54 colonic polyps 54 lactate dehydrogenase 54 precancerous colon polyps 54 solar keratosis 54 Plaque buildup 54 non resectable metastatic 54 postnatally 54 underwent prostate biopsy 54 breast carcinoma 54 helical CT 54 recurrent miscarriages 54 premalignant 54 Calcium intake 54 genital secretions 54 CMV infections 54 breast cancer Narod 54 Adjuvant chemotherapy 54 glioma tumors 54 gastric cardia 54 thyrotropin 54 often detect precancerous 54 endometrial tumors 54 Genetic mutations 54 abnormal Pap 54 CYP#D# inhibitor 54 epigenetic changes 54 drank pomegranate juice 54 Rectal cancer 54 squamous cell skin 54 Thyroid nodules 54 deCODE BreastCancer TM 54 faulty BRCA2 gene 54 menstrual irregularity 54 micro calcifications 54 teratogens 54 Peritoneal mesothelioma 54 Inhibin B 54 BRAF mutations 54 ovarian pancreatic 54 gene APOE4 54 tamoxifen therapy 54 pre cancerous lesions 54 IELT 54 lymphatic cancers 54 Colorectal cancers 54 serous ovarian cancer 54 CIN3 54 dense breasts 54 renal carcinoma 54 Enlarged prostate 54 asymptomatic carotid stenosis 54 biochemical abnormalities 54 trastuzumab Herceptin ® 54 Loeys Dietz 54 BRCA2 carriers 54 cosmetic breast implants 54 visit www.rtanswers.org 54 noncancerous growths 54 colorectal adenomas 54 carotid artery blockage 54 NMIBC 54 prenatal multivitamin 54 ductal lobular 54 cervical colorectal 54 bowel cancers 54 estrogen deficiency 54 Peptide YY 54 recurrent epithelial ovarian 54 leptin deficiency 54 bone marrow suppression 54 basal cell carcinoma BCC 54 chromosomal mutations 54 precancerous growths 54 vaginal cancers 54 prostate pancreatic 54 vaginal lesions 54 estrogen hormone therapy 54 fibrocystic breasts 54 postmenopausal hormones 54 Contraceptive pill 54 hyperplasia BPH 54 Chlamydia infections 54 radiochemotherapy 54 keloid scars 54 serum estradiol 54 Valcyte tablets 54 neutropenic sepsis 54 anthracycline chemotherapy 54 aminotransferases 54 irregular menstruation 54 Robert A. Felberg 54 subarachnoid hemorrhages 54 transferrin saturation 54 metachronous 54 cancerous enlargement 54 limits naphtha waxes 54 basal cell carcinomas 54 mesotheliomas 54 HER2 positive cancers 54 bacterial prostatitis 54 HER2 neu 53 LHRH analogues 53 polypoid lesions 53 axillary lymph nodes 53 papillary renal cell carcinoma 53 benign growths 53 biochemical relapse 53 bilateral oophorectomy 53 Basal cell carcinomas 53 tumors GIST 53 keratoses 53 variant angina 53 precancerous spots 53 pharyngeal cancer 53 C1 INH deficiency 53 oral contraceptives OCs 53 hormone therapy estrogen 53 urethritis 53 troponin T 53 unsightly veins 53 fibrate drugs 53 pulmonary metastases 53 pelvic malignancies 53 cervicitis 53 malignant tissues 53 NP CRNs 53 chlamydial infections 53 malignant lesions 53 ALDH2 deficient 53 ovarian hormones 53 tubal pregnancies 53 serum homocysteine 53 preventive mastectomies 53 sentinel lymph node biopsy 53 male hormone androgen 53 oesophageal 53 cervical lymph nodes 53 prostate cancer CaP 53 precancerous tissue 53 rheumatoid arthritis lupus 53 bowel polyps 53 cervical cancer genital warts 53 blotchy skin bumps 53 benign proliferative breast 53 Secondhand smoke exposure 53 androgen deprivation 53 CHD mortality 53 reproductive abnormalities 53 invasive ductal carcinomas 53 underactive thyroid gland 53 coronary calcification 53 Postmenopausal 53 synthetic progestin 53 dose ionizing radiation 53 underwent brachytherapy 53 hereditary predisposition 53 epithelial tumors 53 human papillomaviruses HPV 53 refractory gastrointestinal stromal 53 Malignant mesothelioma 53 anovulatory infertility 53 abnormal genital 53 Fetal heartbeats 53 prophylactic mastectomies 53 liver metastasis 53 seizures comas 53 serum phosphate 53 TT genotype 53 computerized tomography scans 53 liver scarring 53 mucinous 53 basal cell cancer 53 precancerous cervical lesions 53 microscopic hematuria 53 CIN2 + 53 nonmetastatic 53 primary ovarian insufficiency 53 nonvertebral fractures 53 noncancerous 53 noncancerous tumors 53 Barrett mucosa 53 Melanomas 53 colon adenomas 53 lung nodules 53 epithelial tissues 53 asymptomatic PAD 53 node metastases 53 BRCA2 mutation carriers 53 KRAS mutations 53 sentinel lymph nodes 53 Adenomas 53 papillary carcinoma 53 mammograms Hruska 53 reflux disease GERD 53 menstrual dysfunction 53 Study Tanning beds 53 androgens male 53 Plasma concentrations 53 breast pancreatic 53 CYP#D# gene 53 progestin therapy 53 gallstone disease 53 breast lumps 53 bacteriuria 53 castrate resistant 53 Male infertility 53 placebo dummy pill 53 undergone mastectomy 53 Endometrial 53 obese postmenopausal 53 Bacterial vaginosis 53 male hormones androgens 53 unexplained stillbirth 53 neovasculature 53 AML MDS 53 metastatic prostate 53 adenomatous 53 BRCA carriers 53 operable breast cancer 53 precancers 53 treat menorrhagia 53 Erythropoietic therapies may 53 penile anal 53 intraductal 53 intestinal metaplasia 53 mL/min/#.# m 2 53 treating sarcoma testicular 53 abdominally obese 53 carcinoma HCC 53 acidic reflux 53 antiestrogen 53 cranial irradiation 53 thrombo embolic 53 castration resistant 53 IR Cysteamine 53 androgenic hormones 53 cervical lymph node 53 uterine tumors 53 asymptomatically 53 p# mutations 53 localized prostate 53 #OHD levels 53 PSA nadir 53 precancer 53 genital ulcer 53 orofacial clefts 53 computed tomography CT scans 53 2D 4D ratio 53 vasomotor symptoms associated 53 oral cavity pharynx 53 adnexal masses 53 dysplastic nevi 53 BRCA gene mutation 53 breast tenderness bloating 53 kidney cysts 53 HIV HCV coinfected 53 polycystic ovarian disease 53 uterus fallopian tubes 53 pre cancerous 53 papillomas 53 Miglioretti 53 dilated veins 53 postmenopausal hormone 53 Hair follicles 53 Gabriel Lopez Berestein 53 atypical nevi 53 preventing genital warts 53 asthma hay fever 53 Thal Dex 53 secondary amenorrhea 53 metastatic lymph nodes 53 nodular lesions 53 esophageal cancers 53 Benign breast 53 genital ulcers 53 cancerous polyp 53 metabolized differently 53 systolic dysfunction 53 prostate radical prostatectomy 53 telomeres shorten 53 uterine perforation 53 human papilloma viruses 53 chromosomal rearrangement 53 BRCA2 gene 53 cancerous breast 53 Vaginal bleeding 53 varicoceles 53 genital sores 53 Hashimoto thyroiditis 53 telomere lengths 53 allogeneic HSCT 53 GnRH agonist 53 prior chemotherapy regimens 53 excessive menstrual bleeding 53 ruptured aneurysms 53 prescribe cholesterol lowering 53 cytologic examination 53 C diff infections 53 cardiac troponin T 53 unexplained infertility 53 menarche 53 histological examination 53 arterial thickening 53 DCIS lesions 53 Leydig cell 53 neurocognitive deficits 52 synthetic estrogens 52 dysmenorrhoea 52 mIU ml 52 venous thromboembolisms 52 grade prostatic intraepithelial 52 abnormal Pap tests 52 invasive cervical cancer 52 nonmalignant 52 postoperative morbidity 52 antiplatelet medications 52 hormonal treatments 52 protein excretion 52 microvascular disease 52 alpha1 antitrypsin deficiency 52 SPINK1 52 atrophic vaginitis 52 vulvar cancer 52 pancreatic ovarian 52 stimulate ovulation 52 symptomatic BPH 52 abnormal vaginal bleeding 52 thyroid tumors 52 RYGB surgery 52 parotid salivary gland 52 β blockers 52 Ductal carcinoma 52 oral clodronate 52 chemotherapy cisplatin 52 endometrial cells 52 carotid stenosis 52 cervical abnormalities 52 preeclamptic 52 Prostate Cancer Prostate 52 glandular tissues 52 Uterine fibroids 52 radiation chemoradiation 52 nonalcoholic steatohepatitis NASH 52 non aspirin NSAIDs 52 Breslow thickness 52 TP# mutations 52 lymph node involvement 52 radical mastectomies 52 nonvaccine 52 undergoing androgen deprivation 52 Breast MRIs 52 Elevated PSA 52 PALB2 gene 52 headache nausea fatigue 52 subclinical cardiovascular disease 52 colorectal pancreatic 52 colorectal carcinoma 52 intraperitoneal therapy 52 uterine cancers 52 dyspareunia 52 NKX2 52 prostate testicular 52 removed laparoscopically 52 nulliparous women 52 VTEs 52 mimics estrogen 52 inhibit ovulation 52 obstructive coronary artery 52 syncopal 52 PFOS PFOA 52 Postoperative complications 52 torsade de pointes 52 anticholinergic drugs 52 potentially hepatotoxic 52 intrauterine infection 52 lymph node enlargement 52 Urinary tract infections UTIs 52 enterovirus infection 52 finasteride Proscar 52 hepatocellular carcinomas 52 alkylating agents 52 surgical biopsies 52 fronto temporal dementia 52 anti Mullerian hormone 52 dizziness nausea headaches 52 spontaneous regression 52 teratogenic 52 estradiol gel indicated 52 vulval 52 grade squamous intraepithelial 52 proliferative retinopathy 52 Cotinine 52 endometrial thickness 52 Ionizing radiation 52 axillary node dissection 52 System IPSS 52 undergone hysterectomies 52 methotrexate therapy 52 Iodine counteracts 52 squamous carcinoma 52 pmol L 52 cervical cancer precursors 52 neoplasia 52 underwent prostatectomy 52 suppress ovulation 52 estrogenic effects 52 cancerous polyps 52 nonsmall cell lung cancer 52 sCJD 52 hormone therapy HT 52 Ionising radiation 52 lignan intake 52 malignant brain 52 BRIP1 52 CVD mortality 52 wound dehiscence 52 AGTR1 52 vitamin D inadequacy 52 mmol liter 52 uterine abnormalities 52 IgA deficiency 52 haematologic 52 suppressing ovulation 52 spirometric 52 beta carotene supplementation 52 alleviate menopausal symptoms 52 endometrial kidney 52 triplet pregnancies 52 androgen deficiency 52 dependent neoplasia 52 Clot busting 52 bladder rectum 52 N telopeptide 52 nonfasting triglyceride levels 52 normal karyotype 52 Women 52 myelogenous leukemia 52 pyridostigmine 52 seborrheic keratoses 52 peritoneal carcinomatosis 52 breast conserving lumpectomy 52 narcolepsy cataplexy 52 periocular 52 normal littermates 52 XMRV virus 52 Hepatocellular Carcinoma HCC 52 NNRTI resistance 52 dysfunctional voiding 52 progestin pills 52 spontaneously aborted 52 aminotransferase levels 52 hepatic enzyme 52 LNG IUS 52 highest quintile 52 lymph node removal 52 Li Fraumeni 52 bronchogenic carcinoma 52 spontaneously regress 52 ASPS statistics 52 abnormal cervical 52 painful menstruation 52 micronuclei 52 chromosomal aberrations 52 MYCN amplification 52 oral bisphosphonate 52 resistant hormone refractory 52 oesophageal adenocarcinoma 52 fetal chromosomal 52 hydroxyvitamin D levels 52 ovary uterus 52 Darapladib 52 immuno compromised individuals 52 endogenous estrogen 52 Hemangiomas 52 carcinoids 52 cerebral vascular disease 52 orchiectomy 52 adrenocortical 52 benign prostatic hyperplasia enlarged 52 eccrine 52 sexually transmitted HPV 52 skin wrinkling 52 comedones 52 benign prostate 52 non mutated KRAS 52 androgen suppression 52 antiphospholipid antibodies 52 gastric carcinoma 52 Relapsing remitting MS 52 enamel defects 52 breast tissue 52 hCG Beta 52 endometrial lining 52 conjunctival hyperemia 52 Related Anemia 52 PCOD 52 leptin resistant 52 Squamous cell cancer 52 oncogenic mutations 52 lobular involution 52 recurrent tonsillitis 52 preoperative chemotherapy 52 moderate renal impairment 52 root caries 52 Fragile X gene 52 chemopreventive agent 52 commonest cancers 52 Anthracycline 52 BRCA mutations 52 Hot flushes 52 relapsed MM 52 Sleep disturbances 52 papilloma 52 seminomas 52 Refractory Hodgkin Lymphoma 52 tumor subtypes 52 taxane chemotherapy 52 ASCUS 52 BRCA2 mutation 52 underwent hysterectomy 52 elevated prolactin 52 comorbid illnesses 52 serum calcium levels 52 ovarian colon 52 loop diuretics 52 axillary nodes 52 perineural invasion 52 Oestrogen 52 diastolic blood pressures 52 prenatal exposures 52 pathologic examination 52 CMV antibodies 52 hypertrophic scars 52 fibroadenoma 52 Premenopausal 52 relapsed ALL 52 posterior vitreous detachment 52 stented arteries 52 prostate carcinomas 52 TP# mutation 52 axilla 52 BRAC2 52 lobular 52 invasive ductal carcinoma 52 impaired glucose metabolism 52 preterm deliveries 52 prostate carcinoma 52 Oesophageal cancer 52 recurrent wheezing 52 cancerous growths 52 thicker carotid arteries 52 nanomolar 52 perinatal complications 52 menopausal symptom 52 HPV infections 52 endocrine tumors 52 hormone receptor status 52 cervix vulva 52 Skin lesions 52 proliferative diabetic retinopathy 52 dysplasias 52 MSMB 52 pelvic inflammatory disease 52 Neurology Neurosurgery 52 cancerous lesions 52 metastatic kidney 52 menstrual irregularities 52 habitual snorers 52 GRNOPC1 contains 52 Flexi Scope 52 hypervascular